Docusign, Inc. filings document the public-company record for a cloud software business built around Intelligent Agreement Management, e-signature and contract lifecycle management. Its 8-K reports cover operating results, financial-condition updates, share repurchase authorization disclosures and material governance events, including appointments to the board of directors and related independence determinations.
Proxy materials provide formal disclosure on board structure, director matters, executive compensation, equity awards and stockholder meeting governance. Together, the filings describe Docusign’s reporting obligations, capital-return actions, governance framework and compensation practices alongside the operating performance of its agreement-management software business.
DocuSign (DOCU) Form 144 notice reports a proposed sale of 15,000 shares of common stock through Merrill Lynch, with an aggregate market value of $1,202,850 and an indicated outstanding share count of 201,104,117. The securities were originally acquired in 2008–2009 as initial venture capital funding from Sigma Partners in three lots totaling 15,000 shares. No securities were reported sold in the past three months. The filer affirms no undisclosed material adverse information and includes the standard signature and legal warnings.
Form 144 filed for DOCU discloses a proposed sale of 728 shares of DocuSign common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $58,458.40. The filing lists the approximate date of sale as 09/15/2025 and reports total shares outstanding as 201,104,117. The shares were acquired as restricted stock from the issuer on 08/29/2025 (365 shares) and 09/04/2025 (363 shares), with payment recorded on those same dates. The filer attests they have no undisclosed material information and certifies the accuracy of the notice.
DOCUSIGN, INC. (DOCU) insider sale notice under Rule 144. The filer reports an intended sale of 1,682 restricted common shares, valued at $135,064.60, through Morgan Stanley Smith Barney on 09/15/2025 on NASDAQ. The shares were acquired as restricted stock from the issuer on 08/10/2024. The filing also discloses two recent sales by the same person: 983 shares sold on 09/11/2025 for $78,040.37 and a larger sale of 22,875 shares on 06/18/2025 for $1,710,777.77. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Robert Chatwani, President General Manager, Growth at DocuSign, Inc. (DOCU), reported a sale of company stock on 09/11/2025. The Form 4 shows a disposition of 983 shares at a price of $79.39 per share, leaving 71,143 shares beneficially owned in a direct form. The filing indicates the transaction was executed pursuant to a Rule 10b5-1 trading plan, and the form was signed by an attorney-in-fact.
Teresa Briggs, a director of DocuSign, Inc. (DOCU), reported a sale of common stock under a pre-established plan. On 09/11/2025 she disposed of 364 shares at a price of $79.39 per share. Following the reported transaction she beneficially owned 9,170 shares, held directly. The filing indicates the sale was effected pursuant to a Rule 10b5-1 trading plan and the Form 4 was signed by an attorney-in-fact on her behalf.
Form 144 for DOCU reports a proposed sale of 983 common shares through Morgan Stanley Smith Barney with an aggregate market value of $78,040.37, slated for approximately 09/11/2025 on NASDAQ. The shares were acquired as performance shares from the issuer on 09/10/2024. The filing also discloses a prior sale by an insider, Robert Chatwani, of 22,875 shares on 06/18/2025 for $1,710,777.77. The notice includes the standard certification that the seller is not aware of undisclosed material adverse information at the time of signing.
Form 144 notice for DocuSign, Inc. (DOCU) documents a proposed sale of 364 common shares, with an aggregate market value of $28,897.96, to be executed on 09/11/2025 on NASDAQ through Morgan Stanley Smith Barney LLC, Executive Financial Services. The shares were acquired as restricted stock from the issuer on 05/29/2025 and payment is recorded on that same date. The filing lists total outstanding shares of 201,104,117. The notice includes a representation that the seller does not possess undisclosed material information and references prior sales of 534 shares on 06/16/2025 with gross proceeds of $39,713.58.
Michael G. Rosenbaum, a director of DocuSign, Inc. (DOCU), was granted 6,265 restricted stock units (RSUs) on 09/09/2025. Each RSU converts to one share of common stock upon vesting and was issued at no cash price. The RSUs vest in twelve equal quarterly installments over three years, with a vesting commencement date of 09/03/2025, provided the reporting person remains a service provider through each vesting date. The RSUs do not expire; they either vest or are canceled prior to vesting. The Form 4 was signed by an attorney-in-fact on 09/10/2025.
Initial Form 3 for DocuSign, Inc. (DOCU) reports that Michael George Rosenbaum filed as a director with an event date of 09/03/2025. The filing states no securities are beneficially owned by the reporting person at the time of the statement. The form was signed by an attorney-in-fact on 09/10/2025.
DocuSign reported interim results for the quarter ended July 31, 2025, emphasizing subscription-driven revenue and continued investment in its platform. Subscriptions represented approximately 98% of revenue for the three and six months ended July 31, 2025, and the company reported $2.3 billion of transaction price allocated to remaining performance obligations, with 57% expected to be recognized within 12 months. DocuSign serves over 1.7 million customers and more than a billion users worldwide. Contract assets were $9.9 million as of July 31, 2025. Information technology costs rose, increasing $7.7 million in the three-month period and $14.5 million for the six months ended July 31, 2025, reflecting cloud migration. The company repurchased 4.9 million shares for $384.9 million during the six months and has $1.2 billion of remaining repurchase authorization. DocuSign had a credit facility of $750 million with a $250 million accordion maturing in May 2030 and reported no outstanding borrowings under it as of July 31, 2025. The filing discloses ongoing securities and derivative litigation related to prior-period statements and continued valuation allowances for certain deferred tax assets.